gene

BIRC5

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BIRC5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

65Connections
0Hypotheses
0Analyses
50Outgoing
15Incoming

Summary

BIRC5 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, implicated in. Associated with Als, Cancer, Carcinoma. Connected to 48 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolBIRC5
Full NameSurvivin (Baculoviral IAP Repeat-Containing Protein 5)
AliasesSurvivin
Chromosome17q25.3.
Primary Expressioncancer cells, survivin has since been recognized for its dual functions in both mitotic regulation and apoptosis inhibition [@ambrosini1997]
Molecular Weight16.5 kDa
Amino Acids142 aa
UniProt ID[O15392](https://www.uniprot.org/uniprot/O15392)
Ensembl IDENSG00000089685
OMIM603352
GeneCardsBIRC5
Human Protein AtlasBIRC5
Associated DiseasesCarcinoma, Hepatocellular Carcinoma, Ms
InteractionsCANCER
KG Connections65 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Wiki Pages (14)

Knowledge base pages for this entity

Canonical Page

BIRC5 (Survivin)

gene · 2586 words

YAP/TAZ Signaling Pathway in Neurodegeneration

mechanism · 2603 words

GLI Gene Family

gene · 2171 words

DIABLO

gene · 2135 words

HIF-1α (Hypoxia-Inducible Factor 1-Alpha)

protein · 1867 words

aurkb-protein

protein · 1685 words

Pathway Diagram

graph TD
    BIRC5["<b>BIRC5</b>"]
    Als{"Als"}
    BIRC5 -->|"therapeutic target"| Als
    Cancer{"Cancer"}
    BIRC5 -->|"therapeutic target"| Cancer
    Tumor{"Tumor"}
    BIRC5 -->|"therapeutic target"| Tumor
    Ms{"Ms"}
    BIRC5 -->|"associated with"| Ms
    Carcinoma{"Carcinoma"}
    BIRC5 -->|"associated with"| Carcinoma
    CANCER["CANCER"]
    BIRC5 -->|"therapeutic target"| CANCER
    MDM2["MDM2"]
    BIRC5 -->|"therapeutic target"| MDM2
    Akt(["Akt"])
    BIRC5 -->|"therapeutic target"| Akt
    Mtor(["Mtor"])
    BIRC5 -->|"therapeutic target"| Mtor
    Epigenetic(["Epigenetic"])
    BIRC5 -->|"therapeutic target"| Epigenetic
    Mapk(["Mapk"])
    BIRC5 -->|"therapeutic target"| Mapk
    Pi3K(["Pi3K"])
    BIRC5 -->|"therapeutic target"| Pi3K
    MTOR["MTOR"]
    MTOR -->|"therapeutic target"| BIRC5
    PHOX2B["PHOX2B"]
    PHOX2B -->|"therapeutic target"| BIRC5
    PI3K["PI3K"]
    PI3K -->|"therapeutic target"| BIRC5
    AKT["AKT"]
    AKT -->|"therapeutic target"| BIRC5
    IL6["IL6"]
    IL6 -->|"therapeutic target"| BIRC5
    PER["PER"]
    PER -->|"associated with"| BIRC5
    MYC["MYC"]
    MYC -->|"therapeutic target"| BIRC5
    style BIRC5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (50)

TargetRelationTypeStr
Cancertherapeutic_targetdisease0.75
CANCERtherapeutic_targetgene0.70
Mapktherapeutic_targetpathway0.70
Alstherapeutic_targetdisease0.65
Tumortherapeutic_targetdisease0.65

Incoming (15)

SourceRelationTypeStr
MTORtherapeutic_targetgene0.60
PHOX2Btherapeutic_targetgene0.60
PI3Ktherapeutic_targetgene0.60
AKTtherapeutic_targetgene0.60
IL6therapeutic_targetgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found